Status: Recruiting
Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%
Randomized phase II trial aims to compare surgery with or without adjuvant chemotherapy in treating patients who are pathologically diagnosed as stage I lung adenocarcinoma with micropapillary component no less than 20%.
Participants needed: 460
Trial details
Phase: Phase 2Age: 19-70Biological sex: AllType: InterventionalSponsor: Shanghai Pulmonary Hospital, Shanghai, ChinaUpdated: Dec 19, 2017Locations: 1
Eligibility criteria
Completely resected Stage I NSCLC as defined by the International Staging System [+10]
Do not meet the inclusion criteria [+10]